2020
DOI: 10.1101/2020.05.28.118992
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Within-host genomics of SARS-CoV-2

Abstract: SARS-CoV-2, the causative agent of COVID-19, emerged in late 2019 causing a global pandemic, with the United Kingdom (UK) one of the hardest hit countries. Rapid sequencing and publication of consensus genomes have enabled phylogenetic analysis of the virus, demonstrating SARS-CoV-2 evolves relatively slowly 1 , but with multiple sites in the genome that appear inconsistent with the overall consensus phylogeny 2 . To understand these discrepancies, we used veSEQ 3 , a targeted RNA-seq approach, to quantify min… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

15
75
3

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 58 publications
(93 citation statements)
references
References 51 publications
15
75
3
Order By: Relevance
“…the number of virions that start the infection and produce progeny in the viral population, at around 10 1 -10 3 . Our quantified bottlenecks are based on a substantial number of defined donor-recipient pairs and in agreement with recent studies implying larger bottleneck sizes for SARS-CoV-2 compared to estimates for influenza A virus (23,(26)(27)(28)(29). These bottleneck sizes correlate inversely with higher mutation rates of influenza virus as compared to SARS-CoV-2.…”
Section: Discussionsupporting
confidence: 87%
“…the number of virions that start the infection and produce progeny in the viral population, at around 10 1 -10 3 . Our quantified bottlenecks are based on a substantial number of defined donor-recipient pairs and in agreement with recent studies implying larger bottleneck sizes for SARS-CoV-2 compared to estimates for influenza A virus (23,(26)(27)(28)(29). These bottleneck sizes correlate inversely with higher mutation rates of influenza virus as compared to SARS-CoV-2.…”
Section: Discussionsupporting
confidence: 87%
“…One possible approach is to mask out specific sites in the genome sequence where recurring errors are suspected, as suggested previously [24] . However, genuine recurrent mutations that may contain important information about properties of viral evolution [6,8,[25][26][27] are sometimes hard to distinguish from recurrent systematic errors, and this could obscure important biology. Here, we present data that we hope will help the community make the important decision as to how to treat potential errors in SARS-CoV-2 genome sequences.…”
Section: Figure 1: Effect Of Recurrent Sequencing Mutations On Phylogmentioning
confidence: 99%
“…One possible approach is to mask out specific sites in the genome sequence where recurring errors are suspected, as suggested previously [24]. However, genuine recurrent mutations that may contain important information about properties of viral evolution [7,9,[26][27][28] are sometimes hard to distinguish from recurrent systematic errors, and this could obscure important biology. Here, we present results that we hope will help the community make the critical decision as to how to identify and treat potential errors in SARS-CoV-2 genome sequences.…”
Section: Introductionmentioning
confidence: 99%